Star Sports Medicine Co (HKSE:01609) EBIT: HK$57.6 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01609 Star Sports Medicine Co Ltd HKSE:01609
20 GF Score
Price HK$143.80
! 1 Warning Sign
View Full Analysis

What is Star Sports Medicine Co EBIT?

Star Sports Medicine Co HKSE:01609 -0.21% 20 EBIT is HK$57.6 Mil as of Dec. 2025. GuruFocus rates HKSE:01609 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Star Sports Medicine Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was HK$57.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$57.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Star Sports Medicine Co's annualized ROC % for the quarter that ended in Dec. 2025 was 131.50%. Star Sports Medicine Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 210.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Star Sports Medicine Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.87%.

Star Sports Medicine Co  (HKSE:01609) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Star Sports Medicine Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=231.332 * ( 1 - 9.45% )/( (143.13 + 175.448)/ 2 )
=209.471126/159.289
=131.50 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=742.385 - 79.601 - ( 519.654 - max(0, 100.58 - 638.579+519.654))
=143.13

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=844.099 - 84.471 - ( 596.309 - max(0, 144.52 - 728.7+596.309))
=175.448

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Star Sports Medicine Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=230.3/( ( (98.094 + max(21.292, 0)) + (97.422 + max(2.328, 0)) )/ 2 )
=230.3/( ( 119.386 + 99.75 )/ 2 )
=230.3/109.568
=210.19 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11.072 + 80.875 + 26.295) - (79.601 + 0 + 17.349)
=21.292

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(40.084 + 76.417 + 14.99) - (84.471 + 0 + 44.692)
=2.328

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Star Sports Medicine Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=57.575/6613.434
=0.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Sports Medicine Co EBIT Related Terms

Star Sports Medicine Co EBIT Historical Data

* Premium members only.

The historical data trend for Star Sports Medicine Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Sports Medicine Co EBIT Chart

Star Sports Medicine Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBIT
45.98 70.89 115.22 170.69

Star Sports Medicine Co Quarterly Data
Dec22 Dec23 Dec24 Sep25 Dec25 Jun26
EBIT Get a 7-Day Free Trial 0.00 41.37 0.00 57.58 0.00

HKSE:01609 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Star Sports Medicine Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Star Sports Medicine Co EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Star Sports Medicine Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Star Sports Medicine Co's EV-to-EBIT falls into.


HKSE:01609
20GF Score
Star Sports Medicine Co Ltd HKSE:01609
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Star Sports Medicine Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$57.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$57.6 Mil mean?
Star Sports Medicine Co (HKSE:01609) has a EBIT of HK$57.6 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Star Sports Medicine Co.
Is Star Sports Medicine Co's EBIT too high?
Star Sports Medicine Co's current EBIT is HK$57.6 Mil. Overall, Star Sports Medicine Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Star Sports Medicine Co's EBIT compare to ABT and SYK?
Star Sports Medicine Co's EBIT of HK$57.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Star Sports Medicine Co. Star Sports Medicine Co's current EBIT is HK$57.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Sports Medicine Co stock overvalued right now?
Star Sports Medicine Co (HKSE:01609) has a current EBIT of HK$57.6 Mil. The current EBIT is HK$57.6 Mil. Star Sports Medicine Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Star Sports Medicine Co (HKSE:01609), the current EBIT is HK$57.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Star Sports Medicine Co Business Description

Address No. 25, Jinghai 2nd Road, Beijing Economic and Technological Development Zone, Building 1, A018, B018, Beijing, CHN
Star Sports Medicine Co Ltd is a China-based medical device company specializing in clinical sports medicine solutions. It is principally engaged in the research and development and sales of medical devices and equipment in the field of sports medicine. The product line covers medical implants, surgical equipment and associated medical consumables. The company has only one reportable operating segment, which is the sale of sports medicine products. It derives revenue from the sales of (i) medical implants and (ii) surgical equipment and associated medical consumables, with the majority of revenue generated from the sales of Medical implants. Geographically, the maximum revenue is derived from the Chinese mainland.
20GF Score

Get the complete analysis for HKSE:01609

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$143.80
Price